FDA.reportPublic FDA data

NovoLIN N 100 UNT/ML Injectable Suspension

RxCUI
311027
RxNorm name
NovoLIN N 100 UNT/ML Injectable Suspension
Display name
NovoLIN N 100 UNT/ML Injectable Suspension
Full name
NovoLIN N 100 UNT/ML Injectable Suspension
Term type
PSN
Status
DailyMed mapping
Updated
2026-06-04 23:39:06

Purple Book Biologic Products#

BLA, Proprietary name, Proper name table
BLAProprietary nameProper nameLicense typeStatusLatest source
019959Novolin Ninsulin isophane human351(a)OTC2026-09-01

RxNav Current And Historical NDCs#

RxNav current and historical NDC rows page 1 of 1 · 0 matching rows.

No records found.

UNII Substances#

UNII substance links page 1 of 1 · 0 matching rows.

No records found.

Reported adverse events (FAERS/openFDA)#

Adverse event summaries are temporarily unavailable. Other product information remains available.

DailyMed RxNorm Mappings#

unique DailyMed labels mapped to this RxNorm concept page 1 of 1 · 2 matching rows.

Set ID, RxNorm mappings, Terms table
Set IDRxNorm mappingsTermsSPL versionLabelEffective
82f1445c-b2c6-445a-82cf-ba8825fac776NovoLIN N 100 UNT/ML Injectable Suspension [PSN] · insulin isophane, human 100 UNT/ML Injectable Suspension [Novolin N] [SBD] · Novolin N 100 UNT/ML Injectable Suspension [SY] · ReliOn Novolin N 100 UNT/ML Injectable Suspension [SY]417These highlights do not include all the information needed to use NOVOLIN N safely and effectively. See full prescribing information for NOVOLIN N. NOVOLIN ® N (insulin isophane human) injectable suspension, for subcutaneous use Initial U.S. Approval: 199120221123
99c995f1-522e-42aa-b45a-117e0af77d81NovoLIN N 100 UNT/ML Injectable Suspension [PSN] · insulin isophane, human 100 UNT/ML Injectable Suspension [Novolin N] [SBD] · Novolin N 100 UNT/ML Injectable Suspension [SY] · ReliOn Novolin N 100 UNT/ML Injectable Suspension [SY]42Novolin N NPH, Human Insulin Isophane Suspension (recombinant DNA origin) 100 units/mL20130827